Laine E Thomas Selected Research

Heart Failure

6/2022	Angiotensin Receptor Neprilysin Inhibition and Associated Outcomes by Race and Ethnicity in Patients With Heart Failure With Reduced Ejection Fraction: Data From CHAMP-HF.
1/2022	Treatment Persistence of Renin-Angiotensin-Aldosterone-System Inhibitors Over Time in Heart Failure with Reduced Ejection Fraction.
11/2021	Diuretic Changes, Health Care Resource Utilization, and Clinical Outcomes for Heart Failure With Reduced Ejection Fraction: From the Change the Management of Patients With Heart Failure Registry.
1/2019	Hospital participation in clinical trials for patients with acute myocardial infarction: Results from the National Cardiovascular Data Registry.
1/2018	Risk Score to Predict Need for Intensive Care in Initially Hemodynamically Stable Adults With Non-ST-Segment-Elevation Myocardial Infarction.
6/2015	Digoxin Use and Subsequent Outcomes Among Patients in a Contemporary Atrial Fibrillation Cohort.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Laine E Thomas Research Topics

Disease

12	Atrial Fibrillation 01/2022 - 10/2011
7	Stroke (Strokes) 01/2022 - 10/2011
6	Heart Failure 06/2022 - 06/2015
4	Hemorrhage 01/2022 - 10/2014
3	Embolism (Embolus) 01/2018 - 12/2015
3	Glucose Intolerance 08/2015 - 01/2012
2	COVID-19 01/2023 - 03/2022
2	ST Elevation Myocardial Infarction 01/2018 - 12/2015
2	Chronic Obstructive Pulmonary Disease (COPD) 01/2016 - 01/2012
2	Hypertension (High Blood Pressure) 12/2015 - 01/2012
1	Leiomyoma (Uterine Fibroids) 10/2023
1	Infections 11/2022
1	Acute Coronary Syndrome 01/2022
1	Edema (Dropsy) 11/2021
1	Dyspnea (Shortness of Breath) 11/2021
1	Weight Gain 11/2021
1	Transient Ischemic Attack 01/2018
1	Lung Diseases (Lung Disease) 01/2018
1	Chronic Renal Insufficiency 01/2018
1	Frailty 10/2014
1	Coronary Disease (Coronary Heart Disease) 09/2013
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2012

Drug/Important Bio-Agent (IBA)

3	Vitamin K FDA Link 01/2022 - 12/2015
3	CreatinineIBA 01/2018 - 01/2012
3	Valsartan (Vals)FDA Link 08/2015 - 01/2012
3	Nateglinide (Starlix)FDA LinkGeneric 08/2015 - 01/2012
2	Angiotensin Receptors (Angiotensin II Receptor)IBA 06/2022 - 01/2022
2	Neprilysin (Neutral Endopeptidase)IBA 06/2022 - 01/2022
2	apixabanIBA 01/2022 - 01/2016
2	AnticoagulantsIBA 01/2018 - 01/2018
2	Warfarin (Coumadin)FDA LinkGeneric 01/2016 - 10/2014
2	LDL CholesterolIBA 09/2013 - 01/2012
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2023
1	Oxygen (Dioxygen)IBA 01/2023
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2023
1	VaccinesIBA 03/2022
1	Angiotensin Receptor AntagonistsIBA 01/2022
1	Mineralocorticoid Receptor AntagonistsIBA 01/2022
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2022
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022
1	Furosemide (Lasix)FDA LinkGeneric 11/2021
1	Bumetanide (Bumex)FDA LinkGeneric 11/2021
1	Torsemide (Demadex)FDA LinkGeneric 11/2021
1	Metolazone (Diulo)FDA LinkGeneric 11/2021
1	DiureticsIBA 11/2021
1	omega-Chloroacetophenone (Mace)IBA 01/2019
1	Anti-Arrhythmia AgentsIBA 01/2018
1	TroponinIBA 01/2018
1	ElementsIBA 12/2015
1	Factor Xa (Coagulation Factor Xa)IBA 12/2015
1	RivaroxabanIBA 12/2015
1	Digoxin (Digitek)FDA LinkGeneric 06/2015
1	CholesterolIBA 01/2012
1	AlbuminsIBA 01/2012
1	HDL CholesterolIBA 01/2012

Therapy/Procedure

7	Therapeutics 01/2023 - 10/2011
2	Percutaneous Coronary Intervention 01/2022 - 12/2015
1	Uterine Myomectomy 10/2023
1	Hysterectomy 10/2023
1	Personal Protective Equipment 11/2022
1	Critical Care (Surgical Intensive Care) 01/2018
1	Drug Therapy (Chemotherapy) 01/2018
1	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 12/2015
1	Catheter Ablation 10/2014